BioInfra Life Science (XKRX:266470) EBIT : ₩-2,742.4 Mil (TTM As of Dec. 2024)

BioInfra Life Science EBIT Chart

BioInfra Life Science Annual Data
	Trend	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EBIT		Get a 7-Day Free Trial				-4,020.08	-2,150.92	-1,127.83	-2,009.47	-2,742.41

BioInfra Life Science Semi-Annual Data
	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EBIT	Get a 7-Day Free Trial				-4,020.08	-2,150.92	-1,127.83	-2,009.47	-2,742.41

Competitive Comparison of BioInfra Life Science's EBIT

For the Biotechnology subindustry, BioInfra Life Science's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioInfra Life Science's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioInfra Life Science's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where BioInfra Life Science's EV-to-EBIT falls into.

BioInfra Life Science EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-2,742.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioInfra Life Science  (XKRX:266470) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

BioInfra Life Science's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

where

Note: The Operating Income data used here is one times the annual (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

BioInfra Life Science's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

where Working Capital is:

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

BioInfra Life Science's Earnings Yield (Joel Greenblatt) % for today is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioInfra Life Science EBIT Related Terms

Thank you for viewing the detailed overview of BioInfra Life Science's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

BioInfra Life Science Business Description